FDA Leaders’ Public Health Fundamentals Offer Hope To Sponsors
This article was originally published in The Tan Sheet
Executive Summary
FDA wants to be judged on its overall impact on public health - not on drug approvals - Commissioner Peggy Hamburg and Principal Deputy Josh Sharfstein say in the New England Journal of Medicine